Accessibility Menu
 
Bavarian Nordic A/s logo

Bavarian Nordic A/s

(OTC) BVNKF

Current Price$30.68
Market Cap$2.20B
Since IPO (2003)-19%
5 Year-38%
1 Year+16%
1 Month-8%

Bavarian Nordic A/s Financials at a Glance

Market Cap

$2.20B

Revenue (TTM)

$6.20B

Net Income (TTM)

$1.38B

EPS (TTM)

$2.70

P/E Ratio

10.42

Dividend

$0.00

Beta (Volatility)

0.35 (Low)

Price

$30.68

Volume

200

Open

$30.68

Previous Close

$28.09

Daily Range

$30.68 - $30.68

52-Week Range

$20.71 - $37.60

BVNKF News

No articles available.

BVNKF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bavarian Nordic A/s

Industry

Biotechnology

Employees

1,795

CEO

Paul Chaplin, PhD

Headquarters

Hellerup, 2900, DK

BVNKF Financials

Key Financial Metrics (TTM)

Gross Margin

49%

Operating Margin

28%

Net Income Margin

22%

Return on Equity

12%

Return on Capital

13%

Return on Assets

9%

Earnings Yield

9.60%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.20B

Shares Outstanding

78.27M

Volume

200

Short Interest

0.00%

Avg. Volume

68.853

Financials (TTM)

Gross Profit

$2.92B

Operating Income

$918.69M

EBITDA

$1.63B

Operating Cash Flow

$2.72B

Capital Expenditure

$204.82M

Free Cash Flow

$2.51B

Cash & ST Invst.

$3.33B

Total Debt

$130.57M

Bavarian Nordic A/s Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$1.41B

-32.7%

Gross Profit

$522.26M

-58.4%

Gross Margin

37.04%

N/A

Market Cap

$2.20B

N/A

Market Cap/Employee

$1.34M

N/A

Employees

1,645

N/A

Net Income

$298.12M

-138.7%

EBITDA

$193.08M

-79.1%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$3.20B

+56.1%

Accounts Receivable

$853.70M

-27.6%

Inventory

$2.51B

+7.8%

Long Term Debt

$85.16M

-1.8%

Short Term Debt

$45.41M

+9.3%

Return on Assets

9.20%

N/A

Return on Invested Capital

13.22%

N/A

Free Cash Flow

$444.91M

+37.1%

Operating Cash Flow

$543.81M

-43.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GLPGFGalapagos N.V.
$33.27+43.24%
BRCTFBioArctic AB (publ)
$33.02+0.00%
TLPPFTelix Pharmaceuticals Limited
$8.72-2.37%
HAWPYHaw Par Corporation Limited
$53.50+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$40.25-0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.07+0.02%
ARTLArtelo Biosciences
$11.19+2.51%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.93-0.03%

Questions About BVNKF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.